In 2026, the estimated global pharmaceutical sales in the oncology sector surpassed 232 billion U.S. dollars. While anti-diabetes drug sales are approximately 92 billion U.S. dollars in the same year.
Top therapeutic classes and drugs
In oncologic research and development, drugs for non-small cell lung cancer and breast cancer are among the leading diseases. On the other hand, mental health treatments generated about billion dollars of revenue worldwide. One such drug is Cymbalta, manufactured by Eli Lilly and used to treat major depressive disorder and generalized anxiety disorder.
One of Bristol-Myers Squibb’s most profitable medications was Abilify, a neurology product and blockbuster for many years. Aripiprazole, marketed as Abilify, is used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, among other disorders. Bristol-Myers Squibb’s neuroscience program focuses on the development of therapeutic regimens for disorders that impact the brain and nervous system.
We’re happy to help
Get in touch with us for additional information
Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.